horizant.com
HORIZANT® (gabapentin enacarbil) Extended-Release Tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults. HORIZANT is not recommended for patients who are required to sleep during the daytime and remain awake at night. HORIZANT® (gabapentin enacarbil) Extended-Release Tablets are indicated for the management of postherpetic neuralgia (PHN) in adults.
Social
N/A
App
Category
health/pharmacy
Monetization
Unknown
Domain Information
WHOIS
Date
Created
1999-04-15
Nameservers
ns13.gcd-dns.com
ns14.gcd-dns.com
DNS Records
A
75.2.103.146
US
99.83.188.150
US
AWS Global Accelerator (GLOBAL)
TXT
u019ivuascss40ltgumqspcop8
8dicgjne4aed7tr7osa141ck8f
Site Overview
Site Engagments
57.43%
Bounce Rate
Pages Per Visit
2
Total Visits
11.6K
Time on Site
00:05:21
Traffic Sources
Social
16.91%
Paid
1.42%
Mail
0.10%
Referrals
5.98%
Search
27.28%
Direct
48.30%
Traffic Top 5 Country
100.00%
Review Score
UnknownGoogle Ads Overview
No ads shown in the past year.
Google SEO Overview
Top 5 Competitors (US)
Top 5 Keywords (US)
horizant
TopPagehttps://www.horizant.com/
postherpetic neuralgia
gabapentin enacarbil
TopPagehttps://www.horizant.com/
horizant dosage
Top 5 Pages (US)
TopKeywordhorizant
TopKeywordpostherpetic neuralgia
TopKeywordhorizant coupon
TopKeywordhorizant dosage
TopKeywordphn
Google Indexing Results Overview(About Unknown Results)
Posts
| Title | Author | View | Comments | Last Update |
|---|
2.492547s
